SAN FRANCISCO, May 18 /PRNewswire/ -- BioSpace.com, the global hubsite for the life sciences industry, and GSAS Harvard Biotechnology Club today announced the winners of the first BioSpace.com Biotechnology Business Plan Competition. The contest is part of BioSpace.com's Biotech Beach 2000 Life Sciences Expo, taking place on May 20th in San Diego, California. Biotech Beach 2000 is a full day event that combines forums geared towards professionals, entrepreneurs, students and investors in the life sciences industry with a career fair that attracts recruiters from over 40 companies. The inaugural Business Plan Competition, sponsored by BioSpace.com and held in association with the Harvard University biotechnology student organization, was a nationwide contest open to entrepreneurs with a developed plan seeking financing for their early stage, life sciences based business concept. Winners were chosen by a panel organized by the GSAS Harvard Biotechnology Club. First prize was awarded to Dermamax Technology for their plan to commercialize a technology for the transdermal application of medication. The Dermamax team consists of John Abernathy, Joseph Wagner, and Pratush Gupta, three MBA students from the University of Georgia. Second prize went to NewCo, a proposed spinout from PPL Therapeutics Inc., a leading company in the application of transgenic technology. NewCo intends to develop and commercialize organ xenotransplantation from transgenic pigs. The team consists of five PPL Therapeutics Inc. officers, including Dr. Ron James, CEO, Dr. David Ayares, VP Research and Development, Paul Rohricht, VP Business Development, Dr. Marilyn Moore, Xenotransplantation Program Coordinator and Immunologist, and Dr. Alan Colman, Research Director. Both the first and second contest prizes consist of $1000 and an expense paid trip to San Diego, where the competition culminates with the two chosen winners presenting their business plans to a panel of venture capitalists at Biotech Beach 2000's Start-Up Forum. The Start-Up Forum, a new addition to the expo, is designed to educate entrepreneurs about the basics of starting a life sciences company. Among the many topics covered by the forum are such critical activities for start-up companies as attracting top management and raising money from professional investors. Speakers and panelists include; Alan Paau, Director, Tech Transfer & Intellectual Property Services, University of California San Diego, Doug Kelly, General Partner, Alloy Ventures, Christopher Reinhard, Co-Founder, Pres/COO, Collateral Therapeutics, Inc., Brian Atwood, Managing Director, Versant Ventures, Mike Powell, Managing Director, Sofinnova Ventures, and Drew Senyei, General Partner, Enterprise Partners. "The Start-up Forum and the Business Plan Competition are new vehicles fueled by our industry's reliance on the entrepreneurial spirit," said Norm Wada, Executive Vice President of BioSpace.com. "We believe their addition greatly enhances the Biotech Beach 2000 expo, and subsequently the benefits we bring to the life sciences community through these events." In addition to the Start-up Forum, the Industry Forum is the second forum being inaugurated at Biotech Beach 2000. Coordinated by the Keck Graduate Institute, a pioneering graduate school dedicated to emerging discoveries in the biosciences, the Industry Forum will have a panel of top executives on hand to discuss a range of topics regarding trends in the life-sciences. Speakers include; Joe Panetta, President and CEO, Biocom, David Galas, Chief Academic Officer, KGI Systems, Lewis Shuster, COO, Invitrogen. Panelists and moderators include; Miguel Barbosa, Professor, KGI, Don Bobo, Director of Business Development, Edwards Life Sciences, Graham Lidgard, VP for R&D, Gen-Probe, Mark Brann, Founder, CEO and President, Acadia Pharmaceuticals, Marek Liyanage, Senior Scientist, Aurora Biosciences, Stephen McCormack, Dir. of Science and Tech Development, Keck Graduate Institute, Dr. Stanley Crooke, Founder, Chairman and CEO, Charles Cantor, CSO, Sequenom, Manny Diaz-Conti, Director of Finance, Cypress Biosciences, Daniel Bradbury, Sr. VP of Corporate Development, Amylin, Jay Knowles, VP of Business Development, Structural Genomix, Inc. Returning forums, forum members, sponsors, and participating Career Fair companies include: * Investor Forum -- The forum exposes an audience of retail investors to life sciences investment information traditionally reserved for institutional investors and industry analysts. Guest speakers include Faraz Naqvi of Dresdner RCM Capital and Jim McCamant, founder and editor of the Medical Technology Stock Letter and Agbiotech Stock Letter. Participating companies include; Alliance Pharmaceuticals, Amylin Pharmaceuticals, Aronex Pharmaceuticals, Collateral Therapeutics, Corvas, Diversa Corporation, Epimmune, Gene Logic, Hollis-Eden Pharmaceutical, NPS Pharmaceutical, Trega Biosciences, Vical, and XOMA Corporation. The forum is sponsored by Informed Investors and Incyte Genomics. * Career Forum -- The forum covers employment opportunities in the industry and a discussion on recent trends regarding reapplication of life sciences skills to alternate areas such as marketing, public relations and business development. Guest speakers include; Cynthia Robbins-Roth, Editor-in-Chief, BioVentures Publishing, Subhash B. Karkare, Associate Director, Manufacturing, Amgen, and Judy Fox, Manager of Employment, Allergan. Panel members include: Steve Dahms, Ph.D., San Diego State University, Kate Murashige, Partner, Morrison & Foerster LLP, Emmelyn Eldridge, Ph.D., Medical Writer, IDEC Pharmaceuticals, and Patrick Hankey, Ph.D., Director of Business Development, Clinicor. The forum is sponsored by Next Wave. * Career Fair -- The fair is an offline extension of BioSpace.com's comprehensive life sciences career listings provided on its website. This year's participating companies include; Aerotek Scientific Staffing, Agilent Technologies, Allergan, Alliance Pharmaceuticals, Amgen, Aurora Biosciences, Aviron, Axys Pharmaceuticals, Baxter Hyland Immuno, Bioview, Caliper Technologies, Cell Genesys, ChemBridge, Chemicon, Inc., Digital Gene Technologies, Elan Pharmaceuticals, Exelixis, Inc., Genentech, Gen-Probe Inc./Chugai BioPharmaceuticals, Gilead Sciences, Hollis-Eden Pharmaceuticals, IDEC Pharmaceuticals, Incyte Genomics, Inhale Therapeutics, Keck Graduate Institute, Kelly Scientific Resources, Kforce, Lab Support, Ligand Pharmaceuticals, Merck Research Laboratories, Nanogen, PAREXEL, PE Biosystems, Pharmacyclics, PharmaNet, Pharmingen/BD, Science, Sciencejobs.com, Selective Genetics, Sugen, Trega Biosciences, and Yoh Scientific. Complete details regarding the BioSpace.com Biotech Beach 2000 Life Sciences expo are available at http://www.biospace.com/beach2000 . About BioSpace.com BioSpace.com ( http://www.biospace.com ) is the global hubsite for the life sciences industry. The company has created a point of convergence for those who work in the industry by providing Community, Content and Commerce on a feature-rich platform. BioSpace.com is dedicated to accelerating discovery in the life sciences by facilitating exchange crucial to the industry through the application of contextual commerce, an end-to-end e-commerce solution. BioSpace.com attracts over 2 million page views per month from over 300,000 unique visitors seeking real-time industry news, information resources, investment data, company profiles, stock quotes, employment listings, and an innovative business-to-business (B2B) supply solution developed cooperatively with the National Institute of Health (NIH).